The Physicians Group LLC

The Physicians Group LLC was paid $6.75M by Medicaid between Jan 2018 and Nov 2024, across 73 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 42% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	9,221	$612K
2019	11,618	$719K
2020	9,834	$676K
2021	12,790	$997K
2022	18,978	$1.38M
2023	17,918	$1.43M
2024incomplete	12,273	$937K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	42%	31,095	28,769	$2.83M
99222	Initial hospital care, per day, moderate complexity	21%	12,771	12,714	$1.39M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	20%	22,449	21,177	$1.35M
99203	Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity	4.4%	3,458	3,458	$300K
99232	Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity	2.5%	3,887	2,595	$170K
90460	Immunization administration through 18 years of age via any route, first or only component	1.6%	2,784	2,763	$108K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	1.6%	800	799	$106K
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	<1%	450	436	$64K
99205	Prolong outpt/office vis	<1%	334	334	$58K
99350	Prolong home eval add 15m	<1%	927	891	$49K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	439	438	$44K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	1,039	992	$40K

61 more codes

99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	373	$34K
80050	General health panel	<1%	863	$26K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	213	$17K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	179	$16K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	367	$14K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	819	$12K
99442		<1%	249	$10K
84481		<1%	625	$9K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	177	$9K
72110		<1%	246	$7K
73630		<1%	256	$7K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	17	$7K
84439		<1%	641	$5K
80061	Lipid panel	<1%	413	$5K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	127	$5K
99441		<1%	115	$4K
99309	Subsequent nursing facility care, per day, low to moderate complexity	<1%	183	$4K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	225	$3K
36415	Collection of venous blood by venipuncture	<1%	555	$3K
80305		<1%	278	$3K
73610		<1%	96	$3K
99490	Ccm add 20min	<1%	450	$3K
95816		<1%	12	$3K
99223	Prolong inpt eval add15 m	<1%	27	$3K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	82	$3K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	51	$3K
80053	Comprehensive metabolic panel	<1%	287	$3K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	40	$2K
90686		<1%	828	$2K
83036	Hemoglobin; glycosylated (A1C)	<1%	242	$2K
G0179	Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care	<1%	301	$2K
99443		<1%	16	$2K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	218	$1K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	86	$1K
99406		<1%	108	$1K
99337		<1%	68	$1K
G0181	Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allowed practitioner development and/or revision of care plans	<1%	154	$1K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	12	$1K
99349		<1%	32	$1K
73560		<1%	27	$728.64
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	29	$702.18
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	193	$518.50
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	100	$509.78
73562		<1%	12	$418.62
81025		<1%	53	$383.22
96127		<1%	62	$210.86
99457		<1%	33	$185.92
85027		<1%	27	$155.97
99152		<1%	27	$85.12
87081		<1%	12	$70.80
99421		<1%	26	$25.63
90685		<1%	15	$0.15
96160		0%	1,230	$0.00
90670		0%	78	$0.00
90715		0%	15	$0.00
90633		0%	12	$0.00
Q0244	Injection, casirivimab and imdevimab, 1200 mg	0%	15	$0.00
90649		0%	67	$0.00
90734		0%	46	$0.00
90700		0%	12	$0.00
90647		0%	77	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHARROZ, ASHLEY (CEO)